For chronic pain sufferers, there is a real problem with the abuse of painkillers in the United States. While the number of patients who have a legitimate need for prescription painkillers — 100 million plus — is vastly more than the number of people addicted to painkillers — 11 million — there is a stigma attached to the prescribing, dispensing and utilization of pain medicines.
News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.
The National Association of Chain Drug Stores on Friday released a letter to the editor in response to a Sept. 5 article in The Washington Post about efforts to improve medication adherence through research and patient-focused strategies.
TruTag Technologies is looking to impact the food and drug industry with its edible security platform. “TruTags,” the company's microtags, can help to authenticate products without packaging or labels. DSN recently spoke with Kent Mansfield, president of TruTag Technologies.
Verde Technologies has announced a pilot program for its Deterra Drug Deactivation System that will see the company partner with the Delaware Prescription Action Committee (PDAC) and the Delaware Pharmacists Societyt to combat prescription drug abuse.
Experts from the CVS Health Research Institute, writing today in the Journal of the American Medical Association, are calling for a reconsideration of treatment guidelines for high cholesterol as PCSK9 inhibitors hit the market.
The Food and Drug Administration recently issued its final guidance on the appearance of generic pharmaceuticals, recommending that drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs that they reference.
The average lost time worker's compensation claim for workers using opioid painkillers can total as much as $117,000 — 900% higher than the cost for workers who do not take opioid painkillers, the National Safety Council says.
Drug Store News had the opportunity at McKesson ideaShare 2015 to talk to Bob Lomenick, owner of three Health Mart pharmacies in Holly Springs, Miss., about his pharmacy’s experience with Medication Synchronization and its impact on improved outcomes and patient lives.